Russia: too much, too soon

Russian assets have been on a roll in the past few weeks. But it looks more like a short-term bounce than the start of a long-term recovery.

Russian assets have been on a roll in the past few weeks. The ruble has bounced by more than 15% since mid-January, leading a revival of Eastern European currencies. Russian stocks are up by 15% in ruble terms, while the RTS index, which measures the performance of leading stocks in dollar terms, has bounced by almost 40%.

However, this looks more like a short-term bounce than the start of a long-term recovery, says Heinz Ruettimann of Julius Baer, a private bank. The fundamentals, while very gradually improving, are hardly impressive. Russia has fallen into recession largely due to the collapse in the oil price: oil and gas account for around 60% of exports and 40% of state revenue, so the low oil price has undermined investment, confidence and consumption. International sanctions imposed by Western countries in response to Russia's destabilisation of Ukraine have also squeezed the economy. Hence GDP fell by 3.7% in 2015. Economists surveyed by Bloomberg expect a 1.5% contraction this year and a return to growth in 2017.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Andrew Van Sickle
Editor, MoneyWeek

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.